Phosphotyrosine-specific Phosphatase PTP-SL Regulates the ERK5 Signaling Pathway*

The duration and the magnitude of mitogen-activated protein kinase (MAPK) activation specifies signal identity and thus allows the regulation of diverse cellular functions by the same kinase cascade. A tight and finely tuned regulation of MAPK activity is therefore critical for the definition of a specific cellular response. We investigated the role of tyrosine-specific phosphatases (PTPs) in the regulation of ERK5. Although unique in its structure, ERK5 is activated in analogy to other MAPKs by dual phosphorylation of threonine and tyrosine residues in its activation motif. In this study we concentrated on whether and how PTP-SL, a kinase-interacting motif-containing PTP, might be involved in the down-regulation of the ERK5 signal. We found that both proteins interact directly with each other in vitro and in intact cells, resulting in mutual modulation of their enzymatic activities. PTP-SL is a substrate of ERK5 and independent of phosphorylation binding to the kinase enhances its catalytic phosphatase activity. On the other hand, interaction with PTP-SL not only down-regulates endogenous ERK5 activity but also effectively impedes the translocation of ERK5 to the nucleus. These findings indicate a direct regulatory influence of PTP-SL on the ERK5 pathway and corresponding downstream responses of the cell.

[1]  R. Pulido,et al.  Two Clusters of Residues at the Docking Groove of Mitogen-activated Protein Kinases Differentially Mediate Their Functional Interaction with the Tyrosine Phosphatases PTP-SL and STEP* , 2002, The Journal of Biological Chemistry.

[2]  P. Crespo,et al.  Erk5 Participates in Neuregulin Signal Transduction and Is Constitutively Active in Breast Cancer Cells Overexpressing ErbB2 , 2002, Molecular and Cellular Biology.

[3]  Rosalind A. Segal,et al.  Neurotrophins use the Erk5 pathway to mediate a retrograde survival response , 2001, Nature Neuroscience.

[4]  U. Rapp,et al.  Extracellular signal regulated kinase 5 (ERK5) is required for the differentiation of muscle cells , 2001, EMBO reports.

[5]  Philip R. Cohen,et al.  Effects of MAP kinase cascade inhibitors on the MKK5/ERK5 pathway , 2001, FEBS letters.

[6]  J. Avruch,et al.  Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. , 2001, Physiological reviews.

[7]  L. Cantley,et al.  Differential MAPK Pathways Utilized for HGF- and EGF-dependent Renal Epithelial Morphogenesis* , 2001, The Journal of Biological Chemistry.

[8]  M. White,et al.  ERK5 and ERK2 Cooperate to Regulate NF-κB and Cell Transformation* , 2001, The Journal of Biological Chemistry.

[9]  M. Karin,et al.  Mammalian MAP kinase signalling cascades , 2001, Nature.

[10]  D. Stieber,et al.  Analysis of candidate genes included in the mammary cancer susceptibility 1 (Mcs1) region , 2001, Mammalian Genome.

[11]  E. Nishida,et al.  Identification of a docking groove on ERK and p38 MAP kinases that regulates the specificity of docking interactions , 2001, The EMBO journal.

[12]  S. Poser,et al.  Differential Regulation of Mitogen-Activated Protein Kinases ERK1/2 and ERK5 by Neurotrophins, Neuronal Activity, and cAMP in Neurons , 2001, The Journal of Neuroscience.

[13]  R. Tapping,et al.  Role of BMK1 in regulation of growth factor-induced cellular responses , 2000, Immunologic research.

[14]  T. Mustelin,et al.  Extracellular signals and scores of phosphatases: all roads lead to MAP kinase. , 2000, Seminars in immunology.

[15]  N. Koide,et al.  Big Mitogen-activated Kinase Regulates Multiple Members of the MEF2 Protein Family* , 2000, The Journal of Biological Chemistry.

[16]  S. Keyse,et al.  Protein phosphatases and the regulation of mitogen-activated protein kinase signalling. , 2000, Current opinion in cell biology.

[17]  N. Bucay,et al.  Protein tyrosine phosphatase (PC12, Br7,Sl) family: Expression characterization in the adult human and mouse , 2000 .

[18]  E. Nishida,et al.  A conserved docking motif in MAP kinases common to substrates, activators and regulators , 2000, Nature Cell Biology.

[19]  A. Whitmarsh,et al.  Signal transduction: A central control for cell growth , 2000, Nature.

[20]  Carmen Blanco-Aparicio,et al.  A Novel Regulatory Mechanism of Map Kinases Activation and Nuclear Translocation Mediated by Pka and the Ptp-Sl Tyrosine Phosphatase , 1999, The Journal of cell biology.

[21]  E. Nishida,et al.  Activation of the Protein Kinase ERK5/BMK1 by Receptor Tyrosine Kinases , 1999, The Journal of Biological Chemistry.

[22]  Tomas Mustelin,et al.  Crosstalk between cAMP-dependent kinase and MAP kinase through a protein tyrosine phosphatase , 1999, Nature Cell Biology.

[23]  R. Pulido,et al.  Interaction of Mitogen-activated Protein Kinases with the Kinase Interaction Motif of the Tyrosine Phosphatase PTP-SL Provides Substrate Specificity and Retains ERK2 in the Cytoplasm* , 1999, The Journal of Biological Chemistry.

[24]  T. Mustelin,et al.  Inhibition of T Cell Signaling by Mitogen-activated Protein Kinase-targeted Hematopoietic Tyrosine Phosphatase (HePTP)* , 1999, The Journal of Biological Chemistry.

[25]  A. Ullrich,et al.  PTP‐SL and STEP protein tyrosine phosphatases regulate the activation of the extracellular signal‐regulated kinases ERK1 and ERK2 by association through a kinase interaction motif , 1998, The EMBO journal.

[26]  Shuang Huang,et al.  Bmk1/Erk5 is required for cell proliferation induced by epidermal growth factor , 1998, Nature.

[27]  O. Ornatsky,et al.  Interaction of myocyte enhancer factor 2 (MEF2) with a mitogen-activated protein kinase, ERK5/BMK1. , 1998, Nucleic acids research.

[28]  T. Mustelin,et al.  Negative Regulation of T Cell Antigen Receptor Signal Transduction by Hematopoietic Tyrosine Phosphatase (HePTP)* , 1998, The Journal of Biological Chemistry.

[29]  M. Muda,et al.  Catalytic activation of the phosphatase MKP-3 by ERK2 mitogen-activated protein kinase. , 1998, Science.

[30]  Jiahuai Han,et al.  BMK1/ERK5 regulates serum‐induced early gene expression through transcription factor MEF2C , 1997, The EMBO journal.

[31]  Elizabeth J. Goldsmith,et al.  Activation Mechanism of the MAP Kinase ERK2 by Dual Phosphorylation , 1997, Cell.

[32]  G. Eisenbarth,et al.  Molecular cloning and characterization of the human transmembrane protein tyrosine phosphatase homologue, phogrin, an autoantigen of type 1 diabetes. , 1996, Biochemical and biophysical research communications.

[33]  J. Abe,et al.  Big Mitogen-activated Protein Kinase 1 (BMK1) Is a Redox-sensitive Kinase* , 1996, The Journal of Biological Chemistry.

[34]  Y. Watanabe,et al.  Cloning and expression of PCPTP1 encoding protein tyrosine phosphatase. , 1995, Gene.

[35]  Jiahuai Han,et al.  Primary structure of BMK1: a new mammalian map kinase. , 1995, Biochemical and biophysical research communications.

[36]  T. Hunter,et al.  Transcriptional control by protein phosphorylation: signal transmission from the cell surface to the nucleus , 1995, Current Biology.

[37]  Gaochao Zhou,et al.  Components of a New Human Protein Kinase Signal Transduction Pathway (*) , 1995, The Journal of Biological Chemistry.

[38]  T. Hamaoka,et al.  cDNA Cloning and Characterization of a Novel Receptor-type Protein Tyrosine Phosphatase Expressed Predominantly in the Brain (*) , 1995, The Journal of Biological Chemistry.

[39]  C. Marshall,et al.  Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation , 1995, Cell.

[40]  B. Wieringa,et al.  A novel receptor-type protein tyrosine phosphatase with a single catalytic domain is specifically expressed in mouse brain. , 1995, The Biochemical journal.

[41]  P. Lombroso,et al.  A Neuronal Protein Tyrosine Phosphatase Induced by Nerve Growth Factor (*) , 1995, The Journal of Biological Chemistry.

[42]  H. Griesser,et al.  A hematopoietic protein tyrosine phosphatase (HePTP) gene that is amplified and overexpressed in myeloid malignancies maps to chromosome 1q32.1. , 1994, Leukemia.

[43]  P. Cohen,et al.  Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Comparison of the effects of nerve growth factor and epidermal growth factor. , 1992, The Biochemical journal.

[44]  M. Minden,et al.  Cloning and expression of an inducible lymphoid‐specific, protein tyrosine phosphatase (HePTPase) , 1992, European journal of immunology.

[45]  P. Lombroso,et al.  Molecular characterization of a protein-tyrosine-phosphatase enriched in striatum. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[46]  I. Pastan,et al.  Epidermal-growth-factor-dependent transformation by a human EGF receptor proto-oncogene. , 1987, Science.

[47]  H. Okayama,et al.  High-efficiency transformation of mammalian cells by plasmid DNA. , 1987, Molecular and cellular biology.

[48]  Hermona Soreq,et al.  Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin , 1985, Nature.

[49]  P. Seeburg,et al.  Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells , 1984, Nature.